1. Home
  2. FCPT vs BEAM Comparison

FCPT vs BEAM Comparison

Compare FCPT & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Four Corners Property Trust Inc.

FCPT

Four Corners Property Trust Inc.

N/A

Current Price

$25.48

Market Cap

2.8B

Sector

Real Estate

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$26.08

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCPT
BEAM
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
FCPT
BEAM
Price
$25.48
$26.08
Analyst Decision
Buy
Buy
Analyst Count
5
16
Target Price
$27.80
$49.13
AVG Volume (30 Days)
772.2K
1.7M
Earning Date
05-14-2026
05-15-2026
Dividend Yield
5.73%
N/A
EPS Growth
1.87
82.31
EPS
1.09
N/A
Revenue
$294,132,000.00
$24,000.00
Revenue This Year
$6.47
N/A
Revenue Next Year
$8.15
$35.80
P/E Ratio
$23.49
N/A
Revenue Growth
9.72
33.33
52 Week Low
$22.78
$13.53
52 Week High
$28.98
$36.44

Technical Indicators

Market Signals
Indicator
FCPT
BEAM
Relative Strength Index (RSI) 54.81 43.87
Support Level $25.24 $23.84
Resistance Level $25.98 $29.06
Average True Range (ATR) 0.41 1.96
MACD -0.03 -0.19
Stochastic Oscillator 48.02 14.79

Price Performance

Historical Comparison
FCPT
BEAM

About FCPT Four Corners Property Trust Inc.

Four Corners Property Trust Inc is a real estate investment trust predominantly engaged in the ownership, acquisition and leasing of restaurant and retail properties. The company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. The firm operates through two segments namely, real estate operations and restaurant operations. The real estate operations segment consists of rental revenues generated by leasing restaurant and retail properties to tenants. The restaurant operations segment is conducted through a taxable REIT subsidiary (TRS) and consists of Kerrow Restaurant Operating Business. The firm generates majority of the revenue from the real estate operations segment.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: